25 Stocks Moving In Wednesday's Pre-Market Session

Gainers

  • Staffing 360 Solutions, Inc.. STAF shares rose 14 percent to $1.88 in pre-market trading after reporting Q1 results.
  • Enphase Energy, Inc. ENPH rose 18.3 percent to $11.88 in pre-market trading after the company posted upbeat Q1 results.
  • Nu Skin Enterprises, Inc. NUS shares rose 17.8 percent to $59.90 in pre-market trading after the company reported upbeat Q1 results.
  • Arlo Technologies, Inc. ARLO shares rose 13.4 percent to $4.50 in pre-market trading after the company reported upbeat Q1 results.
  • Motif Bio plc MTFB rose 12.6 percent to $2.42 in pre-market trading after signing an agreement with Lamellar Biomedical.
  • Tandem Diabetes Care, Inc. TNDM rose 8.8 percent to $66.80 in pre-market trading after the company reported upbeat Q1 results and raised its FY19 guidance.
  • American Shared Hospital Services AMS rose 7.2 percent to $2.99 in pre-market trading.
  • Rosehill Resources Inc. ROSE shares rose 6.2 percent to $5.00 in pre-market trading.
  • Akamai Technologies, Inc. AKAM rose 6 percent to $84.87 in pre-market trading after the company reported better-than-expected Q1 EPS and sales results.
  • CVS Health Corporation CVS rose 5.8 percent to $57.51 in pre-market trading after the company reported better-than-expected earnings for its first quarter and raised its FY19 earnings outlook.
  • Twilio Inc. TWLO rose 5.6 percent to $144.74 in pre-market trading after reporting a first-quarter earnings beat.
  • Apple Inc. AAPL rose 5.5 percent to $211.66 in pre-market trading after the company reported upbeat Q2 results and issued strong third-quarter sales guidance.
  • Advanced Micro Devices, Inc. AMD rose 5.1 percent to $29.02 in pre-market trading after reporting a first-quarter earnings beat.
  • The Estée Lauder Companies Inc. EL rose 4.5 percent to $179.80 in pre-market trading after the company posted upbeat Q3 results and issued strong FY19 earnings forecast.
  • Jumei International Holding Limited JMEI rose 5 percent to $2.55 in pre-market trading.


Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Nabriva Therapeutics plc NBRV fell 23.8 percent to $2.28 in pre-market trading. Nabriva Therapeutics received a complete response letter, or CRL, from the FDA for its NDA for Contepo, chemically fosfomycin, injection for treating complicated urinary tract infections, including acute pyelonephritis. The company said the CRL pertains to issues related to facility inspections and manufacturing deficiencies at one of its contract manufacturers, and that it will seek a Type a meeting with the FDA to discuss the findings.
  • Extreme Networks, Inc. EXTR fell 16.4 percent to $6.69 in pre-market trading after the company reported lower-than-expected Q3 results and issued weak Q4 outlook.
  • CalAmp Corp. CAMP fell 11 percent to $13 in pre-market trading after the company reported downbeat Q4 sales and issued weak Q1 earnings forecast.
  • Akoustis Technologies, Inc. AKTS fell 9.1 percent to $6.00 in pre-market trading.
  • SS&C Technologies Holdings, Inc. SSNC fell 8.6 percent to $61.85 in pre-market trading after the company issued weak Q2 sales forecast.
  • C.H. Robinson Worldwide, Inc. CHRW fell 3.7 percent to $78.00 in pre-market trading following Q1 sales miss.
  • Iridium Communications Inc. IRDM fell 3.5 percent to $26.50 in pre-market trading.
  • New Age Beverages Corporation NBEV fell 3.5 percent to $5.21 in pre-market trading after announcing a $100 million common stock offering.
  • Catalyst Pharmaceuticals, Inc. CPRX fell 3.3 percent to $5.55 in pre-market trading.
  • The Clorox Company CLX fell 3.7 percent to $153.70 in pre-market trading after the company reported weaker-than-expected earnings for its third quarter.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!